An outstanding question is how to increase CD8+ T cell tumor infiltration, as it is thought that infiltration of this T cell subtype into tumor cores, rather than mere accumulation along tumor margins, leads to improved patient clinical outcomes (91). This evidence concerns the gene CD8A and neoplasm.